Ophthalmic Drugs Market Size & Share Report, Growth, Trends, 2028

Ophthalmic Drugs Market

Ophthalmic Drugs Market By Disease (Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, and Others), By Drug Class (Antiallergy, Anti-VEGF Agents, Anti-inflammatory, Antiglaucoma, and Others), By Dosage Form (Gels, Eye Solutions, Capsules & Tablets, Eye Drops, and Ointments), By Route Of Administration (Topical, Local Ocular, and Systemic), By Product Type (Prescription Drugs and OTC Drugs), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 - 2028

Category: Pharmaceutical Report Format : PDF Pages: 180 Report Code: ZMR-3372 Published Date: May-2022 Status : Published
Market Size in 2021 Market Forecast in 2028 CAGR (in %) Base Year
USD 38.13 Billion USD 60.31 Billion 5.9% 2021

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Ophthalmic Drugs Market, (2022 - 2028) (USD Billion)
    • 2.2 Global Ophthalmic Drugs Market : snapshot
  • Chapter 3. Global Ophthalmic Drugs Market - Industry Analysis
    • 3.1 Ophthalmic Drugs Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Growing prevalence of eye-related disorders is fueling the market growth
    • 3.3 Market Restraints
      • 3.3.1. Side effects associated with the ophthalmic drugs to restrain the market growth
    • 3.4 Market Opportunities
      • 3.4.1. Increasing approvals of the therapeutics to boost the market growth during the forecast period.
    • 3.5 Market Challenges
      • 3.5.1. Issues related to ocular drug delivery to act as a challenge for market growth
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Disease
      • 3.7.2 Market attractiveness analysis By Drug Class
      • 3.7.3 Market attractiveness analysis By Dosage Form
      • 3.7.4 Market attractiveness analysis By Route of Administration
      • 3.7.5 Market attractiveness analysis By Product Type
  • Chapter 4. Global Ophthalmic Drugs Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Ophthalmic Drugs Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Ophthalmic Drugs Market - Disease Analysis
    • 5.1 Global Ophthalmic Drugs Market overview: By Disease
      • 5.1.1 Global Ophthalmic Drugs Market share, By Disease, 2021 and 2028
    • 5.2 Dry Eye
      • 5.2.1 Global Ophthalmic Drugs Market by Dry Eye, 2022 - 2028 (USD Billion)
    • 5.3 Eye Allergy
      • 5.3.1 Global Ophthalmic Drugs Market by Eye Allergy, 2022 - 2028 (USD Billion)
    • 5.4 Glaucoma
      • 5.4.1 Global Ophthalmic Drugs Market by Glaucoma, 2022 - 2028 (USD Billion)
    • 5.5 Eye Infection
      • 5.5.1 Global Ophthalmic Drugs Market by Eye Infection, 2022 - 2028 (USD Billion)
    • 5.6 Retinal Disorders
      • 5.6.1 Global Ophthalmic Drugs Market by Retinal Disorders, 2022 - 2028 (USD Billion)
    • 5.7 Others
      • 5.7.1 Global Ophthalmic Drugs Market by Others, 2022 - 2028 (USD Billion)
  • Chapter 6. Global Ophthalmic Drugs Market - Drug Class Analysis
    • 6.1 Global Ophthalmic Drugs Market overview: By Drug Class
      • 6.1.1 Global Ophthalmic Drugs Market share, By Drug Class, 2021 and 2028
    • 6.2 Antiallergy
      • 6.2.1 Global Ophthalmic Drugs Market by Antiallergy, 2022 - 2028 (USD Billion)
    • 6.3 Anti-VEGF Agents
      • 6.3.1 Global Ophthalmic Drugs Market by Anti-VEGF Agents, 2022 - 2028 (USD Billion)
    • 6.4 Anti-inflammatory
      • 6.4.1 Global Ophthalmic Drugs Market by Anti-inflammatory, 2022 - 2028 (USD Billion)
    • 6.5 Antiglaucoma
      • 6.5.1 Global Ophthalmic Drugs Market by Antiglaucoma, 2022 - 2028 (USD Billion)
    • 6.6 Others
      • 6.6.1 Global Ophthalmic Drugs Market by Others, 2022 - 2028 (USD Billion)
  • Chapter 7. Global Ophthalmic Drugs Market - Dosage Form Analysis
    • 7.1 Global Ophthalmic Drugs Market overview: By Dosage Form
      • 7.1.1 Global Ophthalmic Drugs Market share, By Dosage Form, 2021 and 2028
    • 7.2 Gels
      • 7.2.1 Global Ophthalmic Drugs Market by Gels, 2022 - 2028 (USD Billion)
    • 7.3 Eye Solutions
      • 7.3.1 Global Ophthalmic Drugs Market by Eye Solutions, 2022 - 2028 (USD Billion)
    • 7.4 Capsules & Tablets
      • 7.4.1 Global Ophthalmic Drugs Market by Capsules & Tablets, 2022 - 2028 (USD Billion)
    • 7.5 Eye Drops
      • 7.5.1 Global Ophthalmic Drugs Market by Eye Drops, 2022 - 2028 (USD Billion)
    • 7.6 Ointments
      • 7.6.1 Global Ophthalmic Drugs Market by Ointments, 2022 - 2028 (USD Billion)
  • Chapter 8. Global Ophthalmic Drugs Market - Route of Administration Analysis
    • 8.1 Global Ophthalmic Drugs Market overview: By Route of Administration
      • 8.1.1 Global Ophthalmic Drugs Market share, By Route of Administration, 2021 and 2028
    • 8.2 Topical
      • 8.2.1 Global Ophthalmic Drugs Market by Topical, 2022 - 2028 (USD Billion)
    • 8.3 Local Ocular
      • 8.3.1 Global Ophthalmic Drugs Market by Local Ocular, 2022 - 2028 (USD Billion)
    • 8.4 Systemic
      • 8.4.1 Global Ophthalmic Drugs Market by Systemic, 2022 - 2028 (USD Billion)
  • Chapter 9. Global Ophthalmic Drugs Market - Product Type Analysis
    • 9.1 Global Ophthalmic Drugs Market overview: By Product Type
      • 9.1.1 Global Ophthalmic Drugs Market share, By Product Type, 2021 and 2028
    • 9.2 Prescription Drugs
      • 9.2.1 Global Ophthalmic Drugs Market by Prescription Drugs, 2022 - 2028 (USD Billion)
    • 9.3 OTC Drugs
      • 9.3.1 Global Ophthalmic Drugs Market by OTC Drugs, 2022 - 2028 (USD Billion)
  • Chapter 10. Ophthalmic Drugs Market - Regional Analysis
    • 10.1 Global Ophthalmic Drugs Market Regional Overview
    • 10.2 Global Ophthalmic Drugs Market Share, by Region, 2021 & 2028 (USD Billion)
    • 10.3. North America
      • 10.3.1 North America Ophthalmic Drugs Market, 2022 - 2028 (USD Billion)
        • 10.3.1.1 North America Ophthalmic Drugs Market, by Country, 2022 - 2028 (USD Billion)
    • 10.4 North America Ophthalmic Drugs Market, by Disease, 2022 - 2028
      • 10.4.1 North America Ophthalmic Drugs Market, by Disease, 2022 - 2028 (USD Billion)
    • 10.5 North America Ophthalmic Drugs Market, by Drug Class, 2022 - 2028
      • 10.5.1 North America Ophthalmic Drugs Market, by Drug Class, 2022 - 2028 (USD Billion)
    • 10.6 North America Ophthalmic Drugs Market, by Dosage Form, 2022 - 2028
      • 10.6.1 North America Ophthalmic Drugs Market, by Dosage Form, 2022 - 2028 (USD Billion)
    • 10.7 North America Ophthalmic Drugs Market, by Route of Administration, 2022 - 2028
      • 10.7.1 North America Ophthalmic Drugs Market, by Route of Administration, 2022 - 2028 (USD Billion)
    • 10.8 North America Ophthalmic Drugs Market, by Product Type, 2022 - 2028
      • 10.8.1 North America Ophthalmic Drugs Market, by Product Type, 2022 - 2028 (USD Billion)
    • 10.4. Europe
      • 10.4.2 Europe Ophthalmic Drugs Market, 2022 - 2028 (USD Billion)
        • 10.4.2.1 Europe Ophthalmic Drugs Market, by Country, 2022 - 2028 (USD Billion)
    • 10.4 Europe Ophthalmic Drugs Market, by Disease, 2022 - 2028
      • 10.4.1 Europe Ophthalmic Drugs Market, by Disease, 2022 - 2028 (USD Billion)
    • 10.5 Europe Ophthalmic Drugs Market, by Drug Class, 2022 - 2028
      • 10.5.1 Europe Ophthalmic Drugs Market, by Drug Class, 2022 - 2028 (USD Billion)
    • 10.6 Europe Ophthalmic Drugs Market, by Dosage Form, 2022 - 2028
      • 10.6.1 Europe Ophthalmic Drugs Market, by Dosage Form, 2022 - 2028 (USD Billion)
    • 10.7 Europe Ophthalmic Drugs Market, by Route of Administration, 2022 - 2028
      • 10.7.1 Europe Ophthalmic Drugs Market, by Route of Administration, 2022 - 2028 (USD Billion)
    • 10.8 Europe Ophthalmic Drugs Market, by Product Type, 2022 - 2028
      • 10.8.1 Europe Ophthalmic Drugs Market, by Product Type, 2022 - 2028 (USD Billion)
    • 10.5. Asia Pacific
      • 10.5.3 Asia Pacific Ophthalmic Drugs Market, 2022 - 2028 (USD Billion)
        • 10.5.3.1 Asia Pacific Ophthalmic Drugs Market, by Country, 2022 - 2028 (USD Billion)
    • 10.4 Asia Pacific Ophthalmic Drugs Market, by Disease, 2022 - 2028
      • 10.4.1 Asia Pacific Ophthalmic Drugs Market, by Disease, 2022 - 2028 (USD Billion)
    • 10.5 Asia Pacific Ophthalmic Drugs Market, by Drug Class, 2022 - 2028
      • 10.5.1 Asia Pacific Ophthalmic Drugs Market, by Drug Class, 2022 - 2028 (USD Billion)
    • 10.6 Asia Pacific Ophthalmic Drugs Market, by Dosage Form, 2022 - 2028
      • 10.6.1 Asia Pacific Ophthalmic Drugs Market, by Dosage Form, 2022 - 2028 (USD Billion)
    • 10.7 Asia Pacific Ophthalmic Drugs Market, by Route of Administration, 2022 - 2028
      • 10.7.1 Asia Pacific Ophthalmic Drugs Market, by Route of Administration, 2022 - 2028 (USD Billion)
    • 10.8 Asia Pacific Ophthalmic Drugs Market, by Product Type, 2022 - 2028
      • 10.8.1 Asia Pacific Ophthalmic Drugs Market, by Product Type, 2022 - 2028 (USD Billion)
    • 10.6. Latin America
      • 10.6.4 Latin America Ophthalmic Drugs Market, 2022 - 2028 (USD Billion)
        • 10.6.4.1 Latin America Ophthalmic Drugs Market, by Country, 2022 - 2028 (USD Billion)
    • 10.4 Latin America Ophthalmic Drugs Market, by Disease, 2022 - 2028
      • 10.4.1 Latin America Ophthalmic Drugs Market, by Disease, 2022 - 2028 (USD Billion)
    • 10.5 Latin America Ophthalmic Drugs Market, by Drug Class, 2022 - 2028
      • 10.5.1 Latin America Ophthalmic Drugs Market, by Drug Class, 2022 - 2028 (USD Billion)
    • 10.6 Latin America Ophthalmic Drugs Market, by Dosage Form, 2022 - 2028
      • 10.6.1 Latin America Ophthalmic Drugs Market, by Dosage Form, 2022 - 2028 (USD Billion)
    • 10.7 Latin America Ophthalmic Drugs Market, by Route of Administration, 2022 - 2028
      • 10.7.1 Latin America Ophthalmic Drugs Market, by Route of Administration, 2022 - 2028 (USD Billion)
    • 10.8 Latin America Ophthalmic Drugs Market, by Product Type, 2022 - 2028
      • 10.8.1 Latin America Ophthalmic Drugs Market, by Product Type, 2022 - 2028 (USD Billion)
    • 10.7. The Middle-East and Africa
      • 10.7.5 The Middle-East and Africa Ophthalmic Drugs Market, 2022 - 2028 (USD Billion)
        • 10.7.5.1 The Middle-East and Africa Ophthalmic Drugs Market, by Country, 2022 - 2028 (USD Billion)
    • 10.4 The Middle-East and Africa Ophthalmic Drugs Market, by Disease, 2022 - 2028
      • 10.4.1 The Middle-East and Africa Ophthalmic Drugs Market, by Disease, 2022 - 2028 (USD Billion)
    • 10.5 The Middle-East and Africa Ophthalmic Drugs Market, by Drug Class, 2022 - 2028
      • 10.5.1 The Middle-East and Africa Ophthalmic Drugs Market, by Drug Class, 2022 - 2028 (USD Billion)
    • 10.6 The Middle-East and Africa Ophthalmic Drugs Market, by Dosage Form, 2022 - 2028
      • 10.6.1 The Middle-East and Africa Ophthalmic Drugs Market, by Dosage Form, 2022 - 2028 (USD Billion)
    • 10.7 The Middle-East and Africa Ophthalmic Drugs Market, by Route of Administration, 2022 - 2028
      • 10.7.1 The Middle-East and Africa Ophthalmic Drugs Market, by Route of Administration, 2022 - 2028 (USD Billion)
    • 10.8 The Middle-East and Africa Ophthalmic Drugs Market, by Product Type, 2022 - 2028
      • 10.8.1 The Middle-East and Africa Ophthalmic Drugs Market, by Product Type, 2022 - 2028 (USD Billion)
  • Chapter 11. Company Profiles
    • 11.1 NOVARTIS AG
      • 11.1.1 Overview
      • 11.1.2 Financials
      • 11.1.3 Product Portfolio
      • 11.1.4 Business Strategy
      • 11.1.5 Recent Developments
    • 11.2 F. HOFFMANN-LA ROCHE LTD
      • 11.2.1 Overview
      • 11.2.2 Financials
      • 11.2.3 Product Portfolio
      • 11.2.4 Business Strategy
      • 11.2.5 Recent Developments
    • 11.3 BAUSCH & LOMB INCORPORATED
      • 11.3.1 Overview
      • 11.3.2 Financials
      • 11.3.3 Product Portfolio
      • 11.3.4 Business Strategy
      • 11.3.5 Recent Developments
    • 11.4 Alcon Inc.
      • 11.4.1 Overview
      • 11.4.2 Financials
      • 11.4.3 Product Portfolio
      • 11.4.4 Business Strategy
      • 11.4.5 Recent Developments
    • 11.5 ABBVIE Inc.
      • 11.5.1 Overview
      • 11.5.2 Financials
      • 11.5.3 Product Portfolio
      • 11.5.4 Business Strategy
      • 11.5.5 Recent Developments
    • 11.6 TEVA PHARMACEUTICAL INDUSTRIES LTD.
      • 11.6.1 Overview
      • 11.6.2 Financials
      • 11.6.3 Product Portfolio
      • 11.6.4 Business Strategy
      • 11.6.5 Recent Developments
    • 11.7 SUN PHARMACEUTICAL INDUSTRIES LIMITED
      • 11.7.1 Overview
      • 11.7.2 Financials
      • 11.7.3 Product Portfolio
      • 11.7.4 Business Strategy
      • 11.7.5 Recent Developments
    • 11.8 SANTEN PHARMACEUTICAL CO. LTD
      • 11.8.1 Overview
      • 11.8.2 Financials
      • 11.8.3 Product Portfolio
      • 11.8.4 Business Strategy
      • 11.8.5 Recent Developments
    • 11.9 REGENERON PHARMACEUTICALS INC.
      • 11.9.1 Overview
      • 11.9.2 Financials
      • 11.9.3 Product Portfolio
      • 11.9.4 Business Strategy
      • 11.9.5 Recent Developments
    • 11.10 PFIZER INC.
      • 11.10.1 Overview
      • 11.10.2 Financials
      • 11.10.3 Product Portfolio
      • 11.10.4 Business Strategy
      • 11.10.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Ophthalmic Drugs Market, 2022 - 2028 (USD Billion)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Ophthalmic Drugs Market attractiveness, By Disease
  • 6. Global Ophthalmic Drugs Market attractiveness, By Drug Class
  • 7. Global Ophthalmic Drugs Market attractiveness, By Dosage Form
  • 8. Global Ophthalmic Drugs Market attractiveness, By Route of Administration
  • 9. Global Ophthalmic Drugs Market attractiveness, By Product Type
  • 10. Global Ophthalmic Drugs Market share by Disease, 2022 and 2028 (USD Billion)
  • 11. Global Ophthalmic Drugs Market by Dry Eye, 2022 - 2028 (USD Billion)
  • 12. Global Ophthalmic Drugs Market by Eye Allergy, 2022 - 2028 (USD Billion)
  • 13. Global Ophthalmic Drugs Market by Glaucoma, 2022 - 2028 (USD Billion)
  • 14. Global Ophthalmic Drugs Market by Eye Infection, 2022 - 2028 (USD Billion)
  • 15. Global Ophthalmic Drugs Market by Retinal Disorders, 2022 - 2028 (USD Billion)
  • 16. Global Ophthalmic Drugs Market by Others, 2022 - 2028 (USD Billion)
  • 17. Global Ophthalmic Drugs Market share by Drug Class, 2022 and 2028 (USD Billion)
  • 18. Global Ophthalmic Drugs Market by Antiallergy, 2022 - 2028 (USD Billion)
  • 19. Global Ophthalmic Drugs Market by Anti-VEGF Agents, 2022 - 2028 (USD Billion)
  • 20. Global Ophthalmic Drugs Market by Anti-inflammatory, 2022 - 2028 (USD Billion)
  • 21. Global Ophthalmic Drugs Market by Antiglaucoma, 2022 - 2028 (USD Billion)
  • 22. Global Ophthalmic Drugs Market by Others, 2022 - 2028 (USD Billion)
  • 23. Global Ophthalmic Drugs Market share by Dosage Form, 2022 and 2028 (USD Billion)
  • 24. Global Ophthalmic Drugs Market by Gels, 2022 - 2028 (USD Billion)
  • 25. Global Ophthalmic Drugs Market by Eye Solutions, 2022 - 2028 (USD Billion)
  • 26. Global Ophthalmic Drugs Market by Capsules & Tablets, 2022 - 2028 (USD Billion)
  • 27. Global Ophthalmic Drugs Market by Eye Drops, 2022 - 2028 (USD Billion)
  • 28. Global Ophthalmic Drugs Market by Ointments, 2022 - 2028 (USD Billion)
  • 29. Global Ophthalmic Drugs Market share by Route of Administration, 2022 and 2028 (USD Billion)
  • 30. Global Ophthalmic Drugs Market by Topical, 2022 - 2028 (USD Billion)
  • 31. Global Ophthalmic Drugs Market by Local Ocular, 2022 - 2028 (USD Billion)
  • 32. Global Ophthalmic Drugs Market by Systemic, 2022 - 2028 (USD Billion)
  • 33. Global Ophthalmic Drugs Market share by Product Type, 2022 and 2028 (USD Billion)
  • 34. Global Ophthalmic Drugs Market by Prescription Drugs, 2022 - 2028 (USD Billion)
  • 35. Global Ophthalmic Drugs Market by OTC Drugs, 2022 - 2028 (USD Billion)
  • 36. Global Ophthalmic Drugs Market share, by Region, 2022 and 2028
  • 37. North America Ophthalmic Drugs Market, 2022 - 2028 (USD Billion)
  • 38. Europe Ophthalmic Drugs Market, 2022 - 2028 (USD Billion)
  • 39. Asia Pacific Ophthalmic Drugs Market, 2022 - 2028 (USD Billion)
  • 40. Latin America Ophthalmic Drugs Market, 2022 - 2028 (USD Billion)
  • 41. The Middle-East and Africa Ophthalmic Drugs Market, 2022 - 2028 (USD Billion)

Table Of Tables

  • 1. Global Ophthalmic Drugs Market: Snapshot
  • 2. Drivers of the Ophthalmic Drugs Market: impact analysis
  • 3. North America Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 4. North America Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 5. North America Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 6. North America Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 7. North America Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 8. U.S. Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 9. U.S. Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 10. U.S. Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 11. U.S. Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 12. U.S. Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 13. Canada Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 14. Canada Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 15. Canada Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 16. Canada Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 17. Canada Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 18. Europe Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 19. Europe Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 20. Europe Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 21. Europe Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 22. Europe Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 23. Germany Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 24. Germany Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 25. Germany Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 26. Germany Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 27. Germany Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 28. France Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 29. France Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 30. France Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 31. France Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 32. France Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 33. U.K. Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 34. U.K. Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 35. U.K. Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 36. U.K. Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 37. U.K. Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 38. Italy Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 39. Italy Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 40. Italy Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 41. Italy Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 42. Italy Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 43. Spain Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 44. Spain Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 45. Spain Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 46. Spain Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 47. Spain Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 48. Rest of Europe Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 49. Rest of Europe Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 50. Rest of Europe Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 51. Rest of Europe Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 52. Rest of Europe Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 53. Asia Pacific Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 54. Asia Pacific Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 55. Asia Pacific Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 56. Asia Pacific Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 57. Asia Pacific Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 58. China Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 59. China Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 60. China Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 61. China Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 62. China Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 63. Japan Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 64. Japan Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 65. Japan Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 66. Japan Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 67. Japan Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 68. India Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 69. India Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 70. India Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 71. India Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 72. India Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 73. South Korea Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 74. South Korea Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 75. South Korea Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 76. South Korea Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 77. South Korea Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 78. South-East Asia Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 79. South-East Asia Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 80. South-East Asia Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 81. South-East Asia Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 82. South-East Asia Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 83. Rest of Asia Pacific Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 84. Rest of Asia Pacific Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 85. Rest of Asia Pacific Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 86. Rest of Asia Pacific Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 87. Rest of Asia Pacific Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 88. Latin America Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 89. Latin America Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 90. Latin America Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 91. Latin America Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 92. Latin America Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 93. Brazil Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 94. Brazil Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 95. Brazil Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 96. Brazil Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 97. Brazil Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 98. Mexico Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 99. Mexico Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 100. Mexico Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 101. Mexico Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 102. Mexico Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 103. Rest of Latin America Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 104. Rest of Latin America Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 105. Rest of Latin America Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 106. Rest of Latin America Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 107. Rest of Latin America Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 108. The Middle-East and Africa Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 109. The Middle-East and Africa Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 110. The Middle-East and Africa Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 111. The Middle-East and Africa Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 112. The Middle-East and Africa Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 113. GCC Countries Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 114. GCC Countries Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 115. GCC Countries Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 116. GCC Countries Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 117. GCC Countries Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 118. South Africa Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 119. South Africa Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 120. South Africa Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 121. South Africa Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 122. South Africa Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 123. Rest of Middle-East Africa Ophthalmic Drugs Market revenue, By Disease, 2022 - 2028 (USD Billion)
  • 124. Rest of Middle-East Africa Ophthalmic Drugs Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
  • 125. Rest of Middle-East Africa Ophthalmic Drugs Market revenue, By Dosage Form, 2022 - 2028 (USD Billion)
  • 126. Rest of Middle-East Africa Ophthalmic Drugs Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 127. Rest of Middle-East Africa Ophthalmic Drugs Market revenue, By Product Type, 2022 - 2028 (USD Billion)

Methodology

FrequentlyAsked Questions

Growing prevalence of eye-related disorders is fueling the market growth. Further, the growing geriatric population is exacerbating the prevalence of ocular disorders, with uncorrected refractive errors and cataracts being the leading causes of visual impairment. The majority of persons with visual problems are above the age of 50. All such factors are fostering market growth.

According to the Zion Market Research report, the global ophthalmic drugs market was worth about 38.13 (USD billion) in 2021 and is predicted to grow to around 60.31 (USD billion) by 2028, with a compound annual growth rate (CAGR) of around 5.9 percent.

North America is predicted to dominate the global ophthalmic drugs market during the forecast period, accounting for major revenue, owing to the high consumer awareness and availability of superior healthcare infrastructure and availability of superior healthcare infrastructure. Furthermore, the presence of prominent competitors in this region, such as Alcon and Pfizer, Inc., is projected to boost the market growth.

Some of the key players operating in the global ophthalmic drugs market include NOVARTIS AG, F. HOFFMANN-LA ROCHE LTD, BAUSCH & LOMB INCORPORATED, Alcon, Inc., ABBVIE Inc., TEVA PHARMACEUTICAL INDUSTRIES LTD., SUN PHARMACEUTICAL INDUSTRIES LIMITED, SANTEN PHARMACEUTICAL CO., LTD, REGENERON PHARMACEUTICALS INC., and PFIZER INC.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed